e-cigs NOT a gateway to new smokers, study finds

[Oilwellian]

95. I went from 36mgs to 0mgs in seven months

and don't miss the nicotine at all. After smoking for 40 years, I never thought I'd put those words in print. I don't miss the nicotine one iota. I expect one day I'll give up the vape completely. Still enjoy going through the motion and the sense of inhaling. That is obviously my greater addiction, but it's by far much better for me than sucking on a cigarette. I consider vapes to be one of the best inventions EVER, and personally know six people who have stopped smoking thanks to this incredible device.

In conclusion, electronic cigarettes have a very good safety profile and are likely to provide a gateway away from rather than into smoking. Users should be allowed to identify a product and dosage that suit them rather than have regulators decide what they must use. Evidence-based and proportionate regulation should be implemented, and all stakeholders should be involved in the regulatory process. If wisely regulated, electronic cigarettes have the potential to obsolete cigarettes and to save millions of lives worldwide. Excessive regulation, on the contrary, will contribute to maintain the existing levels of smoking-related disease, death and health care costs.

Signatories

Professor Jean-François Etter, PhD,

Associate Professor, Privat docent, Institut de santé globale, Faculté de médecine, Université de Genève, Switzerland.


Dr. Konstantinos Farsalinos, MD

Researcher, Onassis Cardiac Surgery Center, Athens, Greece
Researcher, University Hospital Gathuisberg, Leuven, Belgium.


Professor Peter Hajek, PhD

Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry Queen Mary University of London, London, UK.


Dr. Jacques Le Houezec, PhD

Consultant in Public Health, Tobacco dependence, Rennes, France
& Honorary Lecturer, UK Centre for Tobacco Control Studies, University of Nottingham, UK.


Dr. Hayden McRobbie, MB ChB PhD

Reader in Public Health Interventions, Wolfson Institute of Preventive Medicine, Queen Mary University of London, UK.


Professor Chris Bullen, MBChB, PhD

Director, The National Institute for Health Innovation, The University of Auckland, Auckland, New Zealand.


Professor Lynn T. Kozlowski, PhD

Dean, School of Public Health and Health Professions, Professor of Community Health and Health Behavior, University at Buffalo, State University of New York, USA.


Dr. Mitchell Nides, PhD

President, Los Angeles Clinical Trials, Director, Picture Quitting, the Entertainment Industry's, Quit Smoking Program, Burbank, CA 91505, USA.


Professor Dimitris Kouretas, MD

Professor and Deputy Rector University of Thessaly, Greece.


Professor Riccardo Polosa, MD, PhD

Director of the Institute for Internal Medicine and Clinical Immunology, University of Catania, Italy.


Dr. Karl Fagerström, PhD

President, Fagerström Consulting AB, Vaxholm, Sweden.


Professor Martin Jarvis, Dsc

Emeritus Professsor of Health Psychology, Department of Epidemiology & Public Health, University College London, UK.


Dr. Lynne E. Dawkins, PhD

Senior Lecturer in Psychology, School of Psychology, University of East London, Stratford, London, UK.


Dr. Pasquale Caponnetto, Assistant Professor, Researcher

Centro per la Prevenzione e Cura del Tabagismo, Azienda Ospedaliero-Universitaria “Policlinico-V. Emanuele”, Università di Catania, Catania, Italy.


Professor Jonathan Foulds PhD

Professor of Public Health Sciences & Psychiatry, Penn State University, College of Medicine, Cancer Institute, Cancer Control Program, Hershey, PA 17033-0850, USA.

http://www.ecigarette-research.com/web/index.php/2013-04-07-09-50-07/149-tpd-errors